aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline Sidus Space SIDU Q1 2026 Earnings Net Loss Per Share of 008 as Stock Surges 2397 Kinsale Capital Group Q1 2026 Earnings EPS Surpasses Estimates by 672 Brixmor Property Group Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength RYAM Q1 2026 Earnings Significant EPS Miss Amid Stock Resilience